Video_1_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.mp4 by Alexandre Naime Barbosa (4830609)

“…ELISA assays showed venom (melittin and PLA₂) concentrations varying between 0.25 and 1.479 ng/mL prior to treatment. Venom levels decreased in all patients during the hospitalization period. …”

DataSheet_6_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx by Alexandre Naime Barbosa (4830609)

“…ELISA assays showed venom (melittin and PLA₂) concentrations varying between 0.25 and 1.479 ng/mL prior to treatment. Venom levels decreased in all patients during the hospitalization period. …”

DataSheet_1_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx by Alexandre Naime Barbosa (4830609)

“…ELISA assays showed venom (melittin and PLA₂) concentrations varying between 0.25 and 1.479 ng/mL prior to treatment. Venom levels decreased in all patients during the hospitalization period. …”

DataSheet_2_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx by Alexandre Naime Barbosa (4830609)

“…ELISA assays showed venom (melittin and PLA₂) concentrations varying between 0.25 and 1.479 ng/mL prior to treatment. Venom levels decreased in all patients during the hospitalization period. …”

DataSheet_6_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.docx by Alexandre Naime Barbosa (4830609)

“…ELISA assays showed venom (melittin and PLA₂) concentrations varying between 0.25 and 1.479 ng/mL prior to treatment. Venom levels decreased in all patients during the hospitalization period. …”

DataSheet_4_Single-Arm, Multicenter Phase I/II Clinical Trial for the Treatment of Envenomings by Massive Africanized Honey Bee Stings Using the Unique Apilic Antivenom.xlsx by Alexandre Naime Barbosa (4830609)

“…ELISA assays showed venom (melittin and PLA₂) concentrations varying between 0.25 and 1.479 ng/mL prior to treatment. Venom levels decreased in all patients during the hospitalization period. …”

Data_Sheet_2_Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs.docx by Bih-Rong Wei (369553)

“…A single trametinib dose (0.025 mg/kg), sulfated as dimethyl sulfoxide which enhanced its absorption, reached mean maximum concentration (C_max) 0.64 ng/mL [18% coefficient of variation (CV)] at a median time to maximum concentration (T_max) of 1.5 h (hr), and mean area under the concentration-time curve (AUC) 16.8 hr^*ng/mL (14%CV), which were similar when given alone or in combination with sapanisertib. …”

Data_Sheet_1_Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs.docx by Bih-Rong Wei (369553)

“…A single trametinib dose (0.025 mg/kg), sulfated as dimethyl sulfoxide which enhanced its absorption, reached mean maximum concentration (C_max) 0.64 ng/mL [18% coefficient of variation (CV)] at a median time to maximum concentration (T_max) of 1.5 h (hr), and mean area under the concentration-time curve (AUC) 16.8 hr^*ng/mL (14%CV), which were similar when given alone or in combination with sapanisertib. …”

Silencing of miR-214 induces apoptosis in NPC cells. by Zi-Chen Zhang (511377)

Specificities mediating neutralization breadth and potency in the top 42 Protocol C neutralizers. by Elise Landais (845745)

“…Absent (-), very weak (+/-), weak (+), moderate (++), strong (+++), phenotype was attributed based on i) the median fold or average percent decrease in ID50 and ii) the fraction of viruses which neutralization ID50 was decreased <2 fold, <10 <50 fold or <20%, <40%, <60%, <80%. …”

Qualitative comparison of the results of the ISS T-002 and the ISS OBS T-002 up to 48 weeks: central and effector memory T cell phenotype and cellular immune responses. by Barbara Ensoli (120173)

The therapeutic effects of human bone marrow-derived mesenchymal stem cells (MSCs) in IL-1RaKO mice. by Kijun Lee (4888660)

“…Scale bar: 200 μm (50×), 100 μm (100×), and 50 μm (200×). (D) Synovial hyperplasia and cellular infiltrate were each scored on a scale of 0–3. …”

Increased active Rap1 in Rasa3^−/− megakaryocytes. by Patricia Molina-Ortiz (167505)

“…Two independent experiments (quantification of 50 megakaryocytes per experiment,) with mean ± SEM are presented. …”

TGF-β1 is required for NRP2-mediated EMT. by Camille Grandclement (215143)

“…Histone-H1 was used as a control of protein loading. Whereas only 10 µM of SB-431542 decreases the nuclear level of phosphorylated Smad2 in Colo320 cancer cells, doses of 50 µM should be used to decrease the nuclear level of phosphorylated Smad2 in HT29^NRP2 cancer cells. …”

EFFECTS OF SOIL WATER AVAILABILITY AND ORGANIC MATTER CONTENT ON FRUIT YIELD AND SEED OIL CONTENT OF CASTOR BEAN1 by Rogério D. de Lacerda (10383863)

“…On each experimental unit measuring 100 m2, 50 plants were cultivated with a spacing of 2 m × 1 m (24 useful and 26 border plants). …”

Dataset for: Phosphodiesterase 4 Inhibition Reduces Lung Fibrosis Following Targeted Type II Alveolar Epithelial Cell Injury by Thomas H Sisson (5340485)

Influence of seating styles on head and pelvic vertical movement symmetry in horses ridden at trot by Emma Persson-Sjodin (5066837)

Data_Sheet_1_Collateral impact of the COVID−19 pandemic on the use of healthcare resources among people with disabilities.PDF by Minjeong Sohn (13191558)

Image_3_The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans.JPEG by Juan P. Palavicini (11780237)

Model Verification: Mechanisms Lead to Expected Behaviors in Baseline Conditions. by Cordelia Ziraldo (221649)